Get the app
US › Healthcare

Avita Medical Ltd (RCEL)

US · Healthcare · Medical Devices

$16.59+5.80%
Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue
$21.7M
Revenue YoY
+17.8%
Net profit
$-7.7M
EPS
$-0.25
EPS estimate
$-0.39
Net margin
-35.3%

EPS came in at -0.25 against a street estimate of -0.39 — a beat of 35.9%.

Key statistics

Market cap
$491.0M
Forward P/E
10.3
P/B
40.95
Book value
$-0.90
EPS (TTM)
$-1.43
52-week high
$18.07
52-week low
$3.22
50-day MA
$12.54
200-day MA
$6.73
Beta
2.01

Analyst view

Analysts rate Avita Medical Ltd a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $13.47.

Shareholding

Insiders
1.52%
Institutions
16.33%

Largest institutional holders

FundStake
Vanguard Capital Management, LLC4.31%
BlackRock Inc1.83%
Geode Capital Management, LLC1.10%
Marshall Wace Asset Management Ltd1.09%
AQR Capital Management LLC1.04%
Morgan Stanley - Brokerage Accounts0.65%
Vanguard Fiduciary Trust Co0.59%
Goss Wealth Management LLC0.48%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Avita Medical Ltd — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-11-07.